Autism Spectrum Disorders Market Update 2023: to Surpass USD 537 Billion Revenue by 2030, Claims AMR
The global autism spectrum disorders market was valued at $27.3 billion in 2021, and is projected to reach $43.2 billion by 2031, growing at a CAGR of 4.6% from 2022 to 2031.CAGR: 4.6%Current Market Size: USD 27.3 BillionForecast Growing Region: APACLargest Market: North AmericaProjection Time: 2021 – 2031Base Year:...
United States Jazz Pharmaceuticals Earlitec Diagnostics Inc Abbvie Inc Bristol Myers Squibb Co Cognoa Inc
Source: pharmiweb.com